TCM
XBI icon

Telos Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Telos Capital Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,816
Closed -$2.51M – 204
2024
Q4 		$2.51M Buy
27,816
+1,710
+7% +$166K 0.27% 91
2024
Q3 		$2.58M Sell
26,106
-270
-1% -$26.5K 0.27% 91
2024
Q2 		$2.45M Buy
26,376
+91
+0.3% +$8.16K 0.27% 87
2024
Q1 		$2.49M Buy
26,285
+420
+2% +$39K 0.28% 89
2023
Q4 		$2.31M Sell
25,865
-535
-2% -$39.7K 0.28% 86
2023
Q3 		$1.93M Sell
26,400
-305
-1% -$24.4K 0.27% 86
2023
Q2 		$2.22M Sell
26,705
-170
-0.6% -$14.2K 0.3% 85
2023
Q1 		$2.05M Sell
26,875
-5
-0% -$415 0.29% 86
2022
Q4 		$2.23M Buy
26,880
+325
+1% +$26.3K 0.32% 85
2022
Q3 		$2.11M Buy
26,555
+175
+0.7% +$14.8K 0.35% 83
2022
Q2 		$1.96M Buy
+26,380
New +$1.98M 0.3% 92

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Telos Capital Management's XBI Position: Q1 2025 in Review

Telos Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 27,816 shares — an estimated $2.51M sold.

Telos Capital Management first reported a position in XBI in Q2 2022 and held it in 11 quarters. The position peaked at $2.58M in Q3 2024. 682 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

  • Telos Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
  • Telos Capital Management sold 27,816 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $2.51M.
  • Telos Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 11 quarters.
  • Telos Capital Management's State Street SPDR S&P Biotech ETF position peaked at $2.58M in Q3 2024.
  • 682 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Telos Capital Management's 13F filing for Q1 2025, filed 30 Apr 2025.